Our 13th annual Healthcare Fraud & Abuse Review, compiled by the Bass, Berry & Sims Healthcare Fraud & Abuse Task Force, is now available, providing an in-depth look at the key enforcement trends, legal decisions, and settlements shaping the healthcare industry in 2024.
Where did the government focus its civil and criminal enforcement efforts last year? How did those results compare to prior years? With a new administration in Washington, D.C., will enforcement priorities shift in a meaningful way?
These are just a few of the critical questions we explore in this year’s Review, which examines how government agencies approach fraud investigations and what providers can expect in the months ahead.
Inside, we cover:
- The future of the False Claims Act and major court decisions impacting enforcement
- Government scrutiny of provider relief funds and what’s next for compliance
- Trends in Controlled Substances Act and drug diversion enforcement
- Key takeaways on Stark Law, the Anti-Kickback Statute and managed care enforcement
- Cybersecurity challenges and evolving compliance guidance for healthcare organizations
Healthcare fraud enforcement remains a top priority for the government. In FY 2024 alone, healthcare-related cases accounted for $1.67 billion (57%) of total False Claims Act recoveries, marking the 16th consecutive year that federal civil healthcare fraud recoveries have exceeded $1.5 billion.
Now more than ever, staying informed on the latest enforcement developments is essential. Download the full Review for a comprehensive look at the trends shaping the healthcare industry, and don’t miss the complimentary companion webinar on March 20, 2025. Register now.